Parliament Parliament Q&A
India's pharma exports rise to $31.12 billion, 6.6% CAGR since 2014-15
The question asked the Ministry of Commerce and Industry to provide details on the growth of India's pharmaceutical exports, Maharashtra's specific contribution and district-wise data, and government initiatives supporting the…
The question asked the Ministry of Commerce and Industry to provide details on the growth of India's pharmaceutical exports, Maharashtra's specific contribution and district-wise data, and government initiatives supporting the pharmaceutical ecosystem in Maharashtra, particularly Pune.
Asked and answered by: Asked by Dr. Amol Ramsing Kolhe (MP); Answered by the Ministry of Commerce and Industry (Minister Shri Piyush Goyal).
What the government said
- India's pharmaceutical exports increased from US$ 15.43 billion in 2014-15 to US$ 31.12 billion in 2025-26, representing a compound annual growth of about 6.6 per cent.
- Maharashtra contributes approximately 19 per cent of India's pharmaceutical exports, with its own exports rising from US$ 4.48 billion in 2021-22 to US$ 5.94 billion in 2025-26.
- Principal exporting districts in Maharashtra include Pune, Mumbai, Thane, Nashik, Palghar, Raigad, and Chhatrapati Sambhajinagar (Aurangabad).
- Under the Production Linked Incentive (PLI) Scheme, three approved applicants in Pune District have made a cumulative investment of Rs 1,867 crore and employed 1,254 persons as of March 2026.
- The Biopharma SHAKTI scheme has an outlay of Rs 10,000 crore over five years to build a domestic ecosystem for biologics and biosimilars.
- BIRAC programmes in Maharashtra support 156 BIG startups, 32 SEED startups, 21 LEAP startups, and 47 PACE projects since 2014-15.
- The BioE3 Policy supports 23 initiatives in Maharashtra, and the National Biopharma Mission has supported 25 innovators in the state.
- In FY 2025-26, pharmaceutical employment in SEEPZ-SEZ Zone (Maharashtra) totaled 22,220 persons (7,654 in SEZ units and 14,566 in export-oriented units).
Also in the document
- The government stated that figures for 2025-26 are provisional.
- The answer provides district-wise export data for the last five years (FY 2021-22 to FY 2025-26) in Annexure II, but does not provide a single consolidated figure for 'biotechnology hubs' employment separate from the SEZ/EOU totals.
How this was written
An AI model running on our own computer read the government document and wrote this summary. No person has checked it.
✓ Figures checked. Every number in this summary was found in the document by an automated check.
That check compares numbers only. It cannot confirm that the wording says what the document says — so the original document is always the authority.
The original document
Parliament of India — Questions & Answers (Lok Sabha, starred)
Question to govt · Ref. LS Q231 (Session 8) · 4 Aug 2026
Read it here
Discussion
No one has discussed this document yet.